Tag: Evidence-based medicine

by Lucas Randall
Wide-scale access to the Internet has resulted in unprecedented access to information for the average citizen of any developed nation, and the more recent proliferation of mobile data devices and networks have exponentially increased our ability to reference the collective body of knowledge on a whim.
This access comes at a price however, as tech-savvy marketers have outstripped science and education practitioners’ resources, funding and drive to make information easily accessible, effectively saturating the search-engine and news-reporting info-spheres with commerce-driven interpretations of research, opinion, tradition and in many cases, out-right pseudo-science or fraudulent claims.
Whilst most developed economies provide some levels of consumer protection, in Australia including bodies such as the Therapeutic Goods Administration, the Australian Competition and Consumer Commission (ACCC), Australian Securities and Investments Commission (ASIC) various industry ombudsmen and voluntary ‘societies’ with industry codes-of-practice, most consumers have very limited understanding of the significant differences in evidentiary support pharmaceuticals require, for example, as compared with “complimentary” or “alternative” medicines.
View More Some pointers on critically assessing the validity of claims